01 — At a Glance
The Chemical Company That Forgot to Make Money
- 52-Week High / Low₹241 / ₹110
- CMP₹120
- Q3 FY26 Revenue₹719 Cr
- Q3 FY26 PAT₹25.4 Cr
- Annualised EPS (Q3×4)₹3.68
- Book Value₹69.6
- Price to Book1.72x
- Dividend Yield0.42%
- Debt / Equity0.17x
- Full-Year FY25 PAT₹114 Cr
The Audit Trail Speaks: Laxmi Organic just dropped a -34% stock return bomb in 52 weeks. Q3 revenue tumbled 9% YoY while margins got skinned alive. Two gigantic factories (Dahej & Lote) are in their infant stages, bleeding standalone cash, and management keeps saying “Don’t worry, FY28 is when we party.” That’s two fiscal years away. Your portfolio, however, is partying much sooner — but on the roof, in a thunderstorm.
02 — Introduction
The Chemistry of Catastrophe: A Masterclass in Patience No One Asked For
Laxmi Organic Industries is a specialty chemicals company founded in 1989 by the Goenka family — think solvents, acetic acid derivatives, and complex fluorochemicals. If you’ve ever bought anything in a plastic bottle, used a pharmaceutical, or painted a wall in your home, you’ve probably touched a Laxmi product. Silently. Without acknowledgement. Like a good Indian housekeeping staff.
They make three things: Essentials (Ethyl Acetate, Acetic Anhydride — 65–70% of revenue), Specialties (Diketene Derivatives, Fluorochemicals — 30–35% of revenue), and they serve 750+ customers across 55+ countries. They’re ranked globally top 3 in Essentials (outside China) and top 5 in Specialties. It’s genuinely impressive portfolio construction.
Then comes the fun part. In 2024–25, they bet the farm on a ₹1,100 crore capex program to double Specialties revenue by FY28. Two massive factories went live: Dahej (Phase I done, Phase II by Q4) and Lote (Fluorochemicals). These facilities are eating cash, missing volumes, and dragging margins. Meanwhile, global feedstock prices (acetic acid, ethanol) crashed like an INR against the dollar post-budget announcements. And their biggest customer segment, pharma, decided to optimize costs instead of ordering more chemicals.
The stock was at ₹241 just 12 months ago. Today it sits at ₹120. Down 50%. ROCE fell from 9% to 8.56%. Margins were cleaved from double digits to single-digit purgatory. Rating agencies downgraded them in November and March. And management’s answer to all this? “Q1 next year is hard. Q2 is uncertain. Q3 onwards, maybe things stabilize. FY27 is qualification. FY28 is when the money prints.”
That’s corporate Hindi for: “Arre yaar, patience karo. Abhi toh construction chal raha hai.”
From the Concall (Jan 2026): “Revenue from top 10 customers reduced from 41% in FY22 to 25% in 9M FY25 to further 20% in 9M FY26.” Translation: Diversification is real, but so is the fact that nobody’s ordering much anymore.
03 — Business Model: WTF Do They Even Do?
Specialty Chemicals For People Who Don’t Know What Specialty Chemicals Are
Members get full access to every article.
